Gautam Sethi

发表

Nanoformulations of curcumin: An alliance for effective cancer therapeutics

A. Kunnumakkara, Mangala Hegde, Aviral Kumar, 2023, Food Bioscience.

Network of extracellular traps in the pathogenesis of sterile chronic inflammatory diseases: Role of oxidative stress and potential clinical applications.

A. Kunnumakkara, Mangala Hegde, Sosmitha Girisa, 2023, Antioxidants & redox signaling.

Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents

A. Kunnumakkara, Anjana Sajeev, Bandari BharathwajChetty, 2023, Non-coding RNA.

Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy

Zhaowu Ma, Gautam Sethi, Yi-Chi Yang, 2024, Cell death discovery.

Low-dose Olaparib improves septic cardiac function by reducing ferroptosis via accelerated mitophagy flux.

Xue Zeng, Dongyao Hou, Ruixue Liu, 2024, Pharmacological research.

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis.

Gautam Sethi, Yi Qin, Shengjun Xiong, 2023, Cancer letters.

Exploring the nexus of nuclear receptors in hematological malignancies

A. Kunnumakkara, Mangala Hegde, Anjana Sajeev, 2024, Cellular and molecular life sciences : CMLS.

Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges.

A. Kunnumakkara, Aviral Kumar, Bandari BharathwajChetty, 2024, Pharmacological research.

Delineating the role of nuclear receptors in colorectal cancer, a focused review

A. Kunnumakkara, A. Kumar, Aviral Kumar, 2024, Discover. Oncology.

Cuproptosis in cancers: Function and implications from bench to bedside.

Zhaowu Ma, Gautam Sethi, Lingzhi Wang, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Gamma Radiation-Induced Disruption of Cellular Junctions in HUVECs Is Mediated through Affecting MAPK/NF-κB Inflammatory Pathways

Hong Wang, A. Chinnathambi, S. Alharbi, 2019, Oxidative medicine and cellular longevity.

Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy.

A. Kunnumakkara, Mangala Hegde, Sosmitha Girisa, 2024, Phytotherapy research : PTR.

Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma

P. Lobie, Y. Tan, Xi Zhang, 2024, Cell death & disease.

Unlocking the Potential of Berberine: Advancing Cancer Therapy through Chemosensitization and Combination Treatments.

A. Kunnumakara, Anjana Sajeev, B. Sailo, 2024, Cancer letters.

Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics

A. Kunnumakkara, Mangala Hegde, Sosmitha Girisa, 2024, Life Sciences.

Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review

A. Kunnumakkara, Mangala Hegde, M. Alqahtani, 2024, Cancers.

Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy

Zhaowu Ma, Gautam Sethi, Lingzhi Wang, 2024, Cell proliferation.

Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics

Zhaowu Ma, A. Kunnumakkara, Anjana Sajeev, 2024, Frontiers in oncology.

Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution.

Gautam Sethi, Naveen kumar, 2023, Cancer letters.

Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells

C. D. Mohan, Na Young Kim, Gautam Sethi, 2024, Journal of cellular biochemistry.

Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases

A. Kunnumakkara, Mangala Hegde, Ravichandran Vishwa, 2024, Military Medical Research.